The biotech firm’s claim that Pfizer’s vaccine uses its intellectual property won’t result in the product being pulled from the market. Robert Cyran explains why, even if any settlement is relatively modest, the firms are still fighting.
01:07
01:07
01:41
01:06
01:22
00:47
02:00
01:22
02:15
01:45
01:45
01:04
01:59
00:56
01:07
00:42
02:07
02:52
00:37
00:59
00:45
00:39
01:28
00:57
01:00
00:51
01:38
01:01
00:55
00:41
01:16
01:06
01:54
01:43
01:16
02:44
00:43
01:21
03:16
02:48
00:47
01:04
01:07
01:59
00:59
01:28
01:34
01:18
01:23
01:25
01:34
01:11
00:31
01:30
01:07
00:38
00:45
01:09
01:06
00:35
02:07
02:05
01:36
01:23
02:26
01:11
00:28
01:00
01:23
01:27
01:38
00:35
01:29
01:28
02:15
01:47
01:12
03:28
01:01
01:26
01:07
02:52
05:07
01:11
01:42
01:55
01:29
01:01
00:59
00:49
00:57
01:41
02:09
01:36
00:48
01:00
01:46
00:49
02:16
01:14